Table 3.
Laboratory data before the initiation of RRT in the two groups.
| Variables | Diabetic nephropathy | Nephrosclerosis | P value |
|---|---|---|---|
| Serum creatinine (mg/dL) | 8.8 ± 1.4 | 9.9 ± 1.6 | 0.004 |
| eGFR (mL/min/1.73 m2) | 5.5 ± 1.1 | 4.2 ± 0.8 | <0.0001 |
| UACR (mg/gCr) | 3000 [2084, 4184] | 972 [490, 1830] | <0.0001 |
| Hemoglobin (g/dL) | 10.1 ± 0.9 | 10.7 ± 0.9 | 0.290 |
| Serum albumin (g/dL) | 3.3 ± 0.6 | 3.7 ± 0.4 | 0.0012 |
| Total cholesterol (mg/dL) | 173 ± 38 | 167 ± 35 | 0.341 |
| HDL-cholesterol (mg/dL) | 45 ± 13 | 52 ± 13 | 0.013 |
| Triglyceride (mg/dL) | 141 [96, 178] | 94 [76, 127] | <0.0001 |
| Glycated hemoglobin (%) | 6.5 ± 0.7 | 5.6 ± 0.4 | <0.0001 |
| NT-proBNP (pg/mL) | 2670 [1531, 7209] | 1298 [594, 3226] | 0.021 |
| C-reactive protein (mg/dL) | 0.17 [0.10, 0.29] | 0.09 [0.03, 0.14] | <0.0001 |
Data are expressed as mean ± SD or median [interquartile range]. eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; NT-proBNP, N-terminal pro-brain natriuretic peptide; UACR, urinary albumin to creatinine ratio.